News

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Centene (NYSE:CNC) and its peers.

CNC, NESR and ATI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 8, 2026.

SMCI, ADM, ALL, CNC and AVT are five undervalued stocks with strong estimate revisions and growth prospects that could offer more upside in 2026.

Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.

Investors target stocks that have been on a bullish run. Stocks like PRAA, CNC, BILL and PARR are seeing price strength, and the momentum is likely to continue.

UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.

Rising employer healthcare costs could boost Marsh's consulting demand and create growth avenues for UnitedHealth and Centene through cost-control solutions.

Here is how Adicet Bio, Inc. (ACET) and Centene (CNC) have performed compared to their sector so far this year.

CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3rd, 2026.

Why Centene’s New CIO Matters For Investors Centene (CNC) has put technology in the spotlight with the appointment of Bradley Bolivar as Chief Information Officer, effective 31 August 2026, following Brian LeClaire’s planned retirement. For you as an investor, this move signals a clear intention to rely more on data, artificial intelligence and automation to support operations and financial stability. The market has treated the leadership change as a constructive step that fits with Centene’s...

Oscar Health's membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization keep profitability in focus.

Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.

CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CNC, VLO, and LCUT it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 2nd, 2026.

On August 31, Centene Corporation (NYSE:CNC) named Bradley Bolivar its new Chief Information Officer, taking over from Brian LeClaire, who plans to retire by the end of October 2026. Bolivar arrives with nearly three decades of technology leadership, most recently as CIO of Fannie Mae, where his portfolio spanned application development, infrastructure, cybersecurity, data and […]

Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.

CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.

Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.

Bradley Bolivar is taking the reins of Centene’s IT strategy as artificial intelligence drives a sea change for how insurers do business.

CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 31, 2026.

The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.

Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MOH's contract wins, acquisitions and cash generation support growth, but elevated medical costs and valuation pose risks.

COCO, DAR, CNC, EXC and AMRX offer a defensive appeal as consumer confidence hits a 7-month low amid inflation and labor market concerns.

CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 27th, 2026.

Centene's assessed fair value has shifted from US$63.78 to US$71.67, a move that signals a higher valuation framework in current models. Recent analyst commentary connects these higher targets to expectations for cleaner margins, steadier earnings quality and a more supportive view of capital returns, even as Medicaid exposure and policy risk remain key watch points. As you read on, you will see how to track this evolving Centene story and what to watch as the narrative changes over...

HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.

Low P/B stocks Invesco, Centene, Hewlett Packard Enterprise, Gibraltar Industries and Avnet combine value with growth potential.

Centene, Archer-Daniels-Midland, Avnet, Arrow and AMN have been highlighted in this Screen of The Week article.